Contracts › 75N93023F00001
75N93023F00001: Manufacture of Influenza Virus Human Challenge Material for Phase 1 and 2.
Awarded to Idt Biologika Gmbh by National Institutes of Health (NIH).
$4.2Mobligated
$24.3Mpotential value
14 May 2028current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N93023F00001 |
|---|---|
| Vehicle | 75N93018D00011 |
| Awardee | Idt Biologika Gmbh |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541714 Research and Development in Biotechnology (Except Nanobiotechnology) |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Offers received | 3 |
| Period of performance | 26 September 2023 to 14 May 2028 |
| Potential end | 14 May 2028 |
| Estimated recompete solicitation | ~Q4 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541714 contracts · All expiring contracts · USASpending record